- Home
- EXEL vs REXR Comparison
EXEL vs REXR Comparison
Compare EXEL & REXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- REXR
- Stock Information
- Founded
- EXEL 1994
- REXR 2013
- Country
- EXEL United States
- REXR United States
- Employees
- EXEL N/A
- REXR N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- REXR Real Estate Investment Trusts
- Sector
- EXEL Health Care
- REXR Real Estate
- Exchange
- EXEL Nasdaq
- REXR Nasdaq
- Market Cap
- EXEL 9.7B
- REXR 9.6B
- IPO Year
- EXEL 2000
- REXR 2013
- Fundamental
- Price
- EXEL $34.45
- REXR $42.01
- Analyst Decision
- EXEL Buy
- REXR Hold
- Analyst Count
- EXEL 18
- REXR 9
- Target Price
- EXEL $31.72
- REXR $50.89
- AVG Volume (30 Days)
- EXEL 2.6M
- REXR 2.0M
- Earning Date
- EXEL 10-29-2024
- REXR 10-16-2024
- Dividend Yield
- EXEL N/A
- REXR 3.98%
- EPS Growth
- EXEL 441.02
- REXR 17.01
- EPS
- EXEL 1.55
- REXR 1.23
- Revenue
- EXEL $2,081,598,000.00
- REXR $903,937,000.00
- Revenue This Year
- EXEL $20.53
- REXR N/A
- Revenue Next Year
- EXEL $1.54
- REXR $12.78
- P/E Ratio
- EXEL $22.26
- REXR $34.15
- Revenue Growth
- EXEL 17.31
- REXR 18.01
- 52 Week Low
- EXEL $19.20
- REXR $41.16
- 52 Week High
- EXEL $36.60
- REXR $58.02
- Technical
- Relative Strength Index (RSI)
- EXEL 67.10
- REXR 36.61
- Support Level
- EXEL $27.86
- REXR $41.16
- Resistance Level
- EXEL $36.49
- REXR $43.54
- Average True Range (ATR)
- EXEL 0.98
- REXR 0.99
- MACD
- EXEL -0.01
- REXR 0.04
- Stochastic Oscillator
- EXEL 74.10
- REXR 23.88
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in the acquisition, ownership, and operation of industrial properties in Southern California. The company mainly focuses on leasing facilities in infill markets or relatively wealthy urban areas with a general scarcity of developable land. The vast majority of Rexford's real estate portfolio, in terms of square footage, revenue generation, and total value, comprises light manufacturing and distribution warehouse buildings located in Los Angeles and San Diego. The company's tenants are firms in the wholesale and retail, light manufacturing, industrial equipment, and food and beverage industries.